U.S. Markets closed
  • S&P Futures

    3,293.75
    -5.50 (-0.17%)
     
  • Dow Futures

    27,190.00
    +47.00 (+0.17%)
     
  • Nasdaq Futures

    11,083.50
    -66.00 (-0.59%)
     
  • Russell 2000 Futures

    1,486.10
    -2.70 (-0.18%)
     
  • Crude Oil

    39.55
    -0.05 (-0.13%)
     
  • Gold

    1,903.90
    -3.70 (-0.19%)
     
  • Silver

    24.35
    -0.17 (-0.69%)
     
  • EUR/USD

    1.1686
    -0.0023 (-0.1987%)
     
  • 10-Yr Bond

    0.6640
    -0.0070 (-1.04%)
     
  • Vix

    26.86
    -0.92 (-3.31%)
     
  • GBP/USD

    1.2723
    -0.0013 (-0.1056%)
     
  • BTC-USD

    10,532.03
    -9.72 (-0.09%)
     
  • CMC Crypto 200

    223.67
    +9.92 (+4.64%)
     
  • FTSE 100

    5,829.46
    +25.17 (+0.43%)
     
  • Nikkei 225

    23,176.53
    -183.77 (-0.79%)
     

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CEMI, CSPR and BKD

NEW YORK, NY / ACCESSWIRE / July 28, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Chembio Diagnostics, Inc. (NASDAQ: CEMI)
Class Period: March 12, 2020 - June 16, 2020
Lead Plaintiff Deadline: August 17, 2020

According to the filed complaint, defendants engaged in a scheme to deceive the market and a course of conduct that artificially inflated Chembio's stock price and operated as a fraud or deceit by misrepresenting the efficacy of the Company's Dual Path Platform ("DPP") COVID-19 test. Defendants allegedly achieved this by making false statements about Chembio's DPP COVID-19 test, although they knew or at least recklessly disregarded that there were material performance concerns with the test. When defendants' prior misrepresentations were disclosed and became apparent to the market, the price of Chembio stock fell precipitously as the prior artificial inflation came out of Chembio's stock price.

Learn about your recoverable losses in CEMI: http://www.kleinstocklaw.com/pslra-1/chembio-diagnostics-inc-loss-submission-form?id=8213&from=1

Casper Sleep Inc. (NYSE: CSPR)
in or traceable to the Company's public offering conducted on or around February 7, 2020.
Lead Plaintiff Deadline: August 18, 2020

The complaint alleges that throughout the class period Casper Sleep Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) Casper's profit margins were actually declining, rather than growing; (2) Casper was changing an important distribution partner, costing it 130 basis points of gross margin in the first quarter of 2020 alone; (3) Casper was holding a glut of old and outdated mattress inventory that it was selling at steeply discounted clearance prices, further impairing the Company's profitability; (4) Casper was suffering accelerating losses, further placing its ability to achieve positive cash flows and profitability out of reach; (5) Casper's core operations were not profitable, but were causing the Company to suffer over $40 million in negative cash flows during the first quarter of 2020 alone and doubling its quarterly net loss year over year; (6) as a result of the foregoing, Casper's ability to achieve profitability, implement its growth initiatives, and expand internationally had been misrepresented in the documents issued in connection with Casper's initial public offering, as the Company needed to shutter its European operations, halt all international expansion, jettison over one fifth of its global corporate workforce, and significantly curtail new store openings in order to avoid an imminent cash and liquidity crisis, let alone achieve positive operating cash flows; and (7) as a result of the foregoing, Casper's revenue growth rate was not sustainable and had not positioned the Company to achieve profitability.

Learn about your recoverable losses in CSPR: http://www.kleinstocklaw.com/pslra-1/casper-sleep-inc-loss-submission-form?id=8213&from=1

Brookdale Senior Living Inc. (NYSE: BKD)
Class Period: August 10, 2016 - April 29, 2020
Lead Plaintiff Deadline: August 24, 2020

The BKD lawsuit alleges Brookdale Senior Living Inc. made materially false and/or misleading statements and/or failed to disclose during the class period that: (i) Brookdale's financial performance was sustained by, among other things, the Company's purposeful understaffing of its senior living communities; (ii) the foregoing conduct subjected Brookdale to an increased risk of litigation and, once revealed, was foreseeably likely to have a material negative impact on the Company's financial results and reputation; (iii) as a result, the Company's financial results were unsustainable; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in BKD: http://www.kleinstocklaw.com/pslra-1/brookdale-senior-living-inc-loss-submission-form?id=8213&from=1

Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

SOURCE: The Klein Law Firm



View source version on accesswire.com:
https://www.accesswire.com/599190/The-Klein-Law-Firm-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders-of-CEMI-CSPR-and-BKD